{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:16:42Z","timestamp":1791415002544,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R25 NS107185"],"award-info":[{"award-number":["R25 NS107185"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG026572"],"award-info":[{"award-number":["P01AG026572"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R37AG053589"],"award-info":[{"award-number":["R37AG053589"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32AG061897"],"award-info":[{"award-number":["T32AG061897"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.heliyon.2022.e11196","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T03:09:49Z","timestamp":1666408189000},"page":"e11196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics"],"prefix":"10.1016","volume":"8","author":[{"given":"Gregory L.","family":"Branigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Torrandell-Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-6402","authenticated-orcid":false,"given":"Francesca","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Diaz","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-8894","authenticated-orcid":false,"given":"Kathleen","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.heliyon.2022.e11196_bib1","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11196_bib2","first-page":"26","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"1-2","key":"10.1016\/j.heliyon.2022.e11196_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03033380","article-title":"Axonal degeneration and progressive neurologic disability in multiple sclerosis","volume":"5","author":"Bjartmar","year":"2003","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.heliyon.2022.e11196_bib4","series-title":"Axonal Loss in Multiple Sclerosis. Causes and Mechanisms","volume":"122","author":"Criste","year":"2014"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11196_bib5","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11196_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.je.2016.06.006","article-title":"A\u00a0population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus","volume":"27","author":"Hou","year":"2017","journal-title":"J.\u00a0Epidemiol."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11196_bib7","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.2337\/diacare.26.11.3192","article-title":"Type 1 diabetes and multiple sclerosis. A Danish population-based cohort study","volume":"26","author":"Nielsen","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11196_bib8","first-page":"43","article-title":"An association between multiple sclerosis and type I diabetes mellitus","volume":"239","author":"Wertman","year":"1992","journal-title":"J.\u00a0Neurol."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11196_bib9","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/oby.22558","article-title":"Elevated insulin and insulin resistance are associated with altered myelin in cognitively unimpared middle-aged adults","volume":"27","author":"O\u2019Grady","year":"2020","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11196_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","article-title":"Metformin restores CNS remyelination capacity by rejuvenating aged stem cells","volume":"25","author":"Neumann","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.heliyon.2022.e11196_bib11","first-page":"1","article-title":"A\u00a0protective role of glibenclamide in inflammation-associated injury","volume":"2017","author":"Zhang","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.heliyon.2022.e11196_bib12","first-page":"27","article-title":"Hypoglycemic agents and potential anti-inflammatory activity","volume":"9","author":"Kothari","year":"2016","journal-title":"J.\u00a0Inflamm. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11196_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","article-title":"Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis","volume":"73","author":"Negrotto","year":"2016","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11196_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2174\/1389450118666170613081730","article-title":"Metformin, A new era for an old drug in the treatment of immune mediated disease?","volume":"19","author":"Schuiveling","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11196_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21072523","article-title":"Pioglitazone-mediated peroxisome proliferator-activated receptor \u03b3 activation aggravates murine immune-mediated hepatitis","volume":"21","author":"Schulte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e11196_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3940739","article-title":"Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery","volume":"2019","author":"Villarreal-Calder\u00f3n","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11196_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12026-018-9005-8","article-title":"Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.heliyon.2022.e11196_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-1-3","article-title":"Effect of pioglitazone treatment in a patient with secondary multiple sclerosis","volume":"1","author":"Pershadsingh","year":"2004","journal-title":"J.\u00a0Neuroinflammation"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11196_bib19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/brain\/113.6.1597","article-title":"Clinical aspects of multiple sclerosis in north-east scotland with particular reference to its course and prognosis","volume":"113","author":"Phadke","year":"1990","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11196_bib20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1212\/01.wnl.0000237475.01655.9d","article-title":"Is late-onset multiple sclerosis associated with a worse outcome?","volume":"67","author":"Tremlett","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11196_bib21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1212\/WNL.33.12.1537","article-title":"Multiple sclerosis after age 50","volume":"33","author":"Noseworthy","year":"1983","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11196_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007043","article-title":"Validation of an algorithm for identifying MS cases in administrative health claims datasets","volume":"92","author":"Culpepper","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11196_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1541","article-title":"Association between hormone-modulating breast cancer therapies and incidence of neurodegenerative outcomes for women with breast cancer","volume":"3","author":"Branigan","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11196_bib24","first-page":"1","article-title":"Statin therapy and risk of Alzheimer\u2019s and age-related neurodegenerative diseases","volume":"6","author":"Torrandell-Haro","year":"2020","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv."},{"key":"10.1016\/j.heliyon.2022.e11196_bib25","first-page":"1","article-title":"Androgen-targeting therapeutics\u00a0mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer","author":"Branigan","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.heliyon.2022.e11196_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2022.878304","article-title":"Association between specific type 2 diabetes therapies and risk of alzheimer\u2019s disease and related dementias in propensity-score matched type 2 diabetic patients","volume":"14","author":"Torrandell-Haro","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11196_bib27","first-page":"1","article-title":"Association between menopausal hormone therapy and risk of neurodegenerative diseases: implications for precision hormone therapy","volume":"7","author":"Kim","year":"2021","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv."},{"issue":"D1","key":"10.1016\/j.heliyon.2022.e11196_bib28","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to\u00a0the\u00a0DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11196_bib29","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/jcm9051326","article-title":"Clinical characteristics and disability progression of early- and late-onset multiple sclerosis compared to adult-onset multiple sclerosis","volume":"9","author":"Mirmosayyeb","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11196_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple\u00a0sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11196_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/135245859800400612","article-title":"The increased susceptibility of women to multiple sclerosis","volume":"4","author":"Duquette","year":"1998","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11196_bib32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2217\/WHE.10.69","article-title":"Gender issues in multiple sclerosis: an update","volume":"6","author":"Jobin","year":"2010","journal-title":"Wom. Health"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11196_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/brain\/122.4.625","article-title":"The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis","volume":"122","author":"Cottrell","year":"1999","journal-title":"Brain"},{"issue":"22","key":"10.1016\/j.heliyon.2022.e11196_bib34","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005612","article-title":"Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women","volume":"90","author":"Koch-Henriksen","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11196_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrendo.2015.82","article-title":"Perimenopause as a neurological transition state","volume":"11","author":"Brinton","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.heliyon.2022.e11196_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.20904.1","article-title":"Epigenetic regulation of oligodendrocyte myelination in developmental disorders and neurodegenerative diseases","volume":"9","author":"Berry","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.heliyon.2022.e11196_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fnagi.2018.00312","article-title":"Inflammation: bridging age, menopause and APOE\u03b54 genotype to alzheimer\u2019s disease","volume":"10","author":"Mishra","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2022.e11196_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fendo.2019.00265","article-title":"Autoimmune disease in women: endocrine transition and risk across the lifespan","volume":"10","author":"Desai","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11196_bib39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11196_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101829","article-title":"Dynamic neuroimmune profile during mid-life aging in the female brain and implications for alzheimer risk","volume":"23","author":"Mishra","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.heliyon.2022.e11196_bib41","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.21599.1","article-title":"Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases","volume":"9","author":"Wang","year":"2020","journal-title":"F1000Research"},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11196_bib42","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.ebiom.2015.11.002","article-title":"White matter lipids as a ketogenic fuel supply in aging female brain: implications for alzheimer\u2019s disease","volume":"2","author":"Klosinski","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11196_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90084-y","article-title":"Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition","volume":"11","author":"Mosconi","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11196_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/eem.09.44","article-title":"Diabetes is a proinflammatory state: a translational perspective","volume":"5","author":"Devaraj","year":"2010","journal-title":"Expet Rev. Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11196_bib45","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s13300-019-00695-y","article-title":"Type 2 diabetes mellitus and menopausal hormone therapy: an update","volume":"10","author":"Paschou","year":"2019","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11196_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2337\/db18-0638","article-title":"Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1","volume":"68","author":"Yan","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.heliyon.2022.e11196_bib47","article-title":"Estrogen: an emerging regulator of insulin action and mitochondrial function","volume":"2015","author":"Gupte","year":"2015","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.heliyon.2022.e11196_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00640","article-title":"Molecular mechanisms of glucose fluctuations on diabetic complications","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11196_bib49","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/jnnp.2011.240432","article-title":"Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis","volume":"82","author":"Simpson","year":"2011","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.heliyon.2022.e11196_bib50","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult Scler Relat Disord"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022024847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022024847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:33:00Z","timestamp":1790353980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022024847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2405844022024847"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11196","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e11196"}}